In November 2011 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the minor Athlete J-4130 (the Athlete) after his sample tested positive for the prohibited substance terbutaline. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.
The athlete stated, sustained by evidence, that he suffered from asthma and used prescribed medication as treatment without a TUE. Previously the Athlete had informed his doctor that he was an athlete and subject of doping tests.
Without intention to enhance performance, the Panel finds that there was insufficient awareness about doping prevention related to the use of medication and the application of a TUE with the Athlete and the Athlete’s school.
Considering the Athlete’s fault the Japan Anti-Doping Disciplinary Panel decides on 14 November 2011 to impose a 2 month period of ineligibility on the Athlete starting on the date of the provisional suspension i.e. on 4 November 2011.
